Intima Media Thickness in children with growth hormone treatment

Study identification

• EU PAS number:
  EUPAS3800
• Study ID:
  16717
• Official title and acronym:
  Intima Media Thickness in children with growth hormone treatment
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Comparing Intima media thickness (IMT) of children with and without growth hormone treatment (GH) Correlation of IMT to doses of GH, duration of GH treatment, blood pressure, lipids and glucoseComparing IMT in the time period of 1 y under GH treatment
• Study status:
  Finalised

Research institutions and networks

Institutions

Vestische Kinderklinik Datteln

Study timelines

Date when funding contract was signed

Planned:04/02/2013

Actual:04/02/2013

Study start date

Planned:15/04/2013

Actual:15/04/2013

Data analysis start date

Planned:21/04/2014

Actual:21/04/2014

Date of interim report, if expected

Planned:30/06/2014

Actual:30/06/2014

Date of final study report

Planned:24/11/2014

Actual:20/10/2014

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

Ipsen, Vestische Kinderklinik Datteln

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable